Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective.

about

Recommendations for managing a suboptimal response to biologics for moderate-to-severe psoriasis: A Belgian perspective.

Item

http://www.wikidata.org/entity/Q38594683

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Recommendations for managing a ...... riasis: A Belgian perspective.

@en

type

Item

label

Recommendations for managing a ...... riasis: A Belgian perspective.

@en

prefLabel

Recommendations for managing a ...... riasis: A Belgian perspective.

@en

P1476

Recommendations for managing a ...... riasis: A Belgian perspective.

@en

P2093

Fabienne Willaert

http://www.w3.org/2001/XMLSchema#string

Jo L W Lambert

http://www.w3.org/2001/XMLSchema#string

Julien Lambert

http://www.w3.org/2001/XMLSchema#string

Michel de la Brassinne

http://www.w3.org/2001/XMLSchema#string

Pierre-Dominique Ghislain

http://www.w3.org/2001/XMLSchema#string

Siegfried Segaert

http://www.w3.org/2001/XMLSchema#string

P2860

Definition of treatment goals for moderate to severe psoriasis: a European consensus

Off-label biologic regimens in psoriasis: a systematic review of efficacy and safety of dose escalation, reduction, and interrupted biologic therapy

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Outcomes associated with matching patients' treatment preferences to physicians' recommendations: study methodology.

Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis

Assessing response and loss of response to biological therapies in IBD.

Are treatment satisfaction, quality of life, and self-assessed disease severity relevant parameters for patient registries? Experiences from Finnish and Swedish patients with psoriasis.

Obesity and psoriasis: body weight and body mass index influence the response to biological treatment.

Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland.

Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases.

P304

128-133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09546634.2015.1086476

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26415615

http://www.w3.org/2001/XMLSchema#string